Angel signs framework agreement with TransGenRx
Under future technical and commercial agreements, Angel will utilize its GMP facility at Cramlington to expedite and optimize the expression systems provided by TransGenRx. TransGenRx chief scientific officer
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.